Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-07-05

FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin's generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride for hypertension under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Benazepril Hydrochloride (Amlodipine besylate and benazepril hydrochloride)

Snippet

ORIG AP for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)